{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:37:26Z","timestamp":1794537446216,"version":"4.9.1"},"reference-count":33,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2005,8,19]],"date-time":"2005-08-19T00:00:00Z","timestamp":1124409600000},"content-version":"vor","delay-in-days":352,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2004,9]]},"abstract":"<jats:p>Gain\u2010of\u2010function mutations of the c\u2010<jats:italic>kit<\/jats:italic> gene and the expression of phosphorylated KIT are found in most gastrointestinal stromal tumors and mastocytosis. Further, almost all gonadal seminomas\/ dysgerminomas exhibit KIT membranous staining, and several reports have clarified that some (10\u201325%) have a c\u2010<jats:italic>kit<\/jats:italic> gene mutation. But, whether intracranial germinomas also have a c\u2010<jats:italic>kit<\/jats:italic> gene mutation remains unsolved. To elucidate the presence, frequency, and location of c\u2010<jats:italic>kit<\/jats:italic> gene mutations in intracranial germinomas, we analyzed five mutational hot spots (exons 9, 10, 11, 13, and 17) in the c\u2010<jats:italic>kit<\/jats:italic> genomic DNA of 16 germinomas using polymerase chain reaction and direct sequencing. We found c\u2010<jats:italic>kit<\/jats:italic> gene mutations at exon 11 (W557C) or 17 (D816V, D820V, and N822Y) in four germinomas (25.0%), although no statistically significant difference in any clinicopathological factor was found between patients with or without mutations. These results are similar to those seen in gonadal seminoma\/dysgerminoma patients, and confirm that intracranial germinomas are exact counterparts of gonadal seminomas\/dysgerminomas, as would be expected on histological and immunohistochemical grounds. Moreover, molecular targeting drugs such as imatinib mesylate (STI571), which is a selective inhibitor of KIT, might be promising agents for the treatment of intracranial germinomas with c\u2010<jats:italic>kit<\/jats:italic> gene mutations.<\/jats:p>","DOI":"10.1111\/j.1349-7006.2004.tb03251.x","type":"journal-article","created":{"date-parts":[[2005,8,19]],"date-time":"2005-08-19T10:08:14Z","timestamp":1124446094000},"page":"716-720","source":"Crossref","is-referenced-by-count":66,"title":["c\u2010<i>kit<\/i> gene mutations in intracranial germinomas"],"prefix":"10.1111","volume":"95","author":[{"given":"Yuji","family":"Sakuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Oguni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsugu","family":"Hironaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,8,19]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-5107(01)00117-8"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-2725(99)00076-X"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03343784"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116761"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.4.1609"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.279.5350.577"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64946-2"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64795-5"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH818>3.0.CO;2-E"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.33024"},{"key":"e_1_2_1_12_2","first-page":"8118","article-title":"KIT activation is a ubiquitous feature of gastrointestinal stromal tumors","volume":"61","author":"Rubin BP","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2001.tb01121.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1999.tb00715.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65419-3"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.LAB.0000032410.46986.7B"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2003.tb01470.x"},{"key":"e_1_2_1_18_2","first-page":"7674","article-title":"Stem cell factor receptor (c\u2010KIT) codon 816 mutations predict development of bilateral testicular germ\u2010cell tumors","volume":"63","author":"Looijenga LH","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63120-3"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-3816"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020461"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.5.1741"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711770307"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-199502000-00073"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2002.97.1.0177"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2042.x"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200002000-00045"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10804"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601464"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.22.1733"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.47.8.771"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.190"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M209321200"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-003-0049-0"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2004.tb03251.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2004.tb03251.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T05:37:27Z","timestamp":1700199447000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2004.tb03251.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["10.1111\/j.1349-7006.2004.tb03251.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2004.tb03251.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}